SZSE Ticker: 300485

Beijing Science Sun Pharmaceutical Co., Ltd.

北京赛升药业股份有限公司

赛升药业

SCIENCE SUN

Listing Date: 2015-06-26

Board: GEM

Industry Classification: Manufacturing

On the evening of May 12th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

Post date May 12, 2022 — 19:50 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics

Post date May 5, 2022 — 06:19 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm

Post date May 4, 2022 — 02:56 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times.

Post date May 3, 2022 — 20:41 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm

Post date May 3, 2022 — 19:46 Post Lock

Highlights of important announcements of listed companies on April 29: Laobaiganjiu’s first-quarter net profit increased by 373.72% year-on-year – yqqlm

Post date April 28, 2022 — 23:21 Post Lock

Highlights of the main notices and announcements of listed companies on April 29: Laobaiganjiu's first-quarter net profit increased by 373.72% year-on-year.

Post date April 28, 2022 — 23:06 Post Lock

Saisheng Pharmaceutical (300485): Change of Subsidiary's Drug Production License CFi.CN China Financial Network

Post date April 28, 2022 — 23:03 Post Lock

[First Quarterly Report] Saisheng Pharmaceutical (300485): 2022 First Quarterly Report Disclosure Announcement CFi.CN Zhongcai Network

Post date April 28, 2022 — 23:03 Post Lock

Saisheng Pharmaceutical (300485): The company sold the property and completed the transfer- CFi.CN Zhongcai Network

Post date April 28, 2022 — 23:03 Post Lock

Saisheng Pharmaceutical (300485): Change of the company's drug production license CFi.CN Zhongcai Network

Post date April 28, 2022 — 23:03 Post Lock

Saisheng Pharmaceutical (300485): Resolutions of the 16th Meeting of the 4th Supervisory Committee CFi.CN

Post date April 28, 2022 — 23:03 Post Lock

Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm

Post date April 26, 2022 — 19:51 Post Lock

just! How much impact will the central bank's comprehensive RRR cut have on A shares? The new crown detection leader staged "Tiandi", and the list of concept stocks with high performance was released

Post date April 15, 2022 — 19:45 Post Lock

just! How much impact will the central bank's comprehensive RRR cut have on A shares? New crown detection leader staged "Tiandi", and the list of concept stocks with high performance was released! Stocks Financial World

Post date April 15, 2022 — 19:45 Post Lock

New York Reports Two New Omicron Subtype Variants Highly Infectious

Post date April 15, 2022 — 02:55 Post Lock

The concept of new crown detection broke out. This company made 150 million a day in the first quarter, the stock price was three consecutive boards, and the performance of these companies increased significantly

Post date April 14, 2022 — 21:35 Post Lock

The concept of new crown detection broke out. This company earned 150 million a day in the first quarter, the stock price tripled, and the performance of these companies increased significantly – yqqlm

Post date April 14, 2022 — 19:35 Post Lock

Saisheng Pharmaceutical: It is estimated that the net profit in the first quarter is about 102 million yuan to 115 million yuan, a year-on-year increase of 140% to 170%.

Post date April 13, 2022 — 15:59 Post Lock

[China Securities Pre-market] CITIC Securities disclosed its first-quarter results; Sanan Optoelectronics plans to repurchase shares between 500 million and 800 million yuan; international oil prices soared by more than 6%

Post date April 13, 2022 — 12:29 Post Lock

Want to see more data? Registered subscribers can see all the data.